Search Results - Jansak, Buffy

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma

    Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma by Farag, Sherif S, Zhang, Shuhong, Jansak, Buffy S, Wang, Xiaojing, Kraut, Eric, Chan, Kenneth, Dancey, Janet E, Grever, Michael R

    Published in Leukemia research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease

    Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease by Poi, Ming J., Hofmeister, Craig C., Johnston, Jeffrey S., Edwards, Ryan B., Jansak, Buffy S., Lucas, David M., Farag, Sherif S., Dalton, James T., Devine, Steven M., Grever, Michael R., Phelps, Mitch A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics

    The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics by Wear, Sandra, Richardson, Paul G., Revta, Carolyn, Vij, Ravi, Fiala, Mark, Lonial, Sagar, Francis, Dixil, Siegel, David Samuel diCapua, Schramm, Alex, Jakubowiak, Andrzej J., Harvey, Colleen K., Reece, Donna E., Gul, Engin, Jagannath, Sundar, La, Lisa, Hofmeister, Craig C., Jansak, Buffy, Stewart, Keith, Hagerty, Rachel, Wolf, Jeffrey L., Davis, Beth, Krishnan, Amrita, Duarte, Lupe, Zimmerman, Todd M., Cisneros, Angela, Kumar, Shaji, Birgin, Ann, Ott, Robert, Tasca, Leah, Kelley, Susan L., Anderson, Kenneth C., Giusti, Kathy

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation

    Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation by Hamadani, Mehdi, Hofmeister, Craig C, Jansak, Buffy, Phillips, Gary, Elder, Patrick, Blum, William, Penza, Sam, Lin, Thomas S, Klisovic, Rebecca, Marcucci, Guido, Farag, Sherif S, Devine, Steven M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: